Apyx Medical Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Apyx Medical Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q3 2024.
  • Apyx Medical Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $997K, a 26.2% decline year-over-year.
  • Apyx Medical Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $4.09M, a 30% decline year-over-year.
  • Apyx Medical Corp annual Share-based Payment Arrangement, Expense for 2023 was $5.11M, a 23.6% decline from 2022.
  • Apyx Medical Corp annual Share-based Payment Arrangement, Expense for 2022 was $6.7M, a 31.6% increase from 2021.
  • Apyx Medical Corp annual Share-based Payment Arrangement, Expense for 2021 was $5.09M, a 20.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.09M $997K -$354K -26.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $4.44M $1.05M -$432K -29.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $4.88M $1.13M -$239K -17.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $5.11M $914K -$727K -44.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $5.84M $1.35M -$341K -20.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $6.18M $1.48M -$232K -13.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $6.41M $1.37M -$283K -17.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $6.7M $1.64M +$300K +22.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $6.4M $1.69M +$508K +42.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $5.89M $1.71M +$345K +25.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $5.54M $1.65M +$456K +38.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $5.09M $1.34M +$340K +34% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $4.75M $1.18M +$121K +11.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $4.63M $1.37M +$272K +24.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $4.36M $1.19M +$145K +13.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $4.21M $1M +$3.97M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $240K $1.06M -$2.15M -66.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $2.39M $1.1M -$1.05M -48.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $3.44M $1.05M -$146K -12.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $3.58M -$2.97M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $3.21M +$2.72M +556% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $2.15M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.2M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 $489K +$298K +156% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-15
Q4 2017 $871K $339K +$63K +22.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-31
Q3 2017 $808K $191K +$18K +10.4% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $790K $182K -$2K -1.09% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $792K $159K -$17K -9.66% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $809K $276K Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 $173K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $184K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $176K -$118M -99.9% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-11
Q1 2015 $119M +$36.6M +44.6% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-08
Q3 2014 $128K Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-10
Q1 2014 $82M +$82M +163900% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-15
Q1 2013 $50K Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.